Finance

Lists
INDGN:NSE
Indegene Ltd
595,80 INR
+0,78%
(+4,60) 1D
16 ოქტ, 14:41:07 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for INDGN...
Open
588,80 INR
High
598,00 INR
Low
584,20 INR
Mkt. cap
142,83 მლრ.
Avg. vol.
446,78 ათ.
Volume
91,52 ათ.
Dividend
0,38%
Quarterly dividend
0,56 INR
Ex-dividend date
31 ივლ. 2026
P/E ratio
35,85
52-wk high
627,00 INR
52-wk low
414,00 INR
EPS
16,62 INR
No. of employees
5 ათ.
Open
588,80 INR
High
598,00 INR
Low
584,20 INR
Mkt. cap
142,83 მლრ.
Avg. vol.
446,78 ათ.
Volume
91,52 ათ.
Dividend
0,38%
Quarterly dividend
0,56 INR
Ex-dividend date
31 ივლ. 2026
P/E ratio
35,85
52-wk high
627,00 INR
52-wk low
414,00 INR
EPS
16,62 INR
No. of employees
5 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
34 წუთის წინ
Pega Stock Gets Analyst Backing Ahead Of Results
Investor's Business Daily
Investor's Business Daily
·
6 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOმანიშ გუპტა
Employees4,69 ათ.
Founded1998
Headquarters-
SectorHealth care
Next call 14 დღეში
პარ, 30 ოქტ, 04:30
Fiscal period
Q2 2027
- / 4,63 INR
Revenue / Est. (INR)
- / 11,04 მლრდ.
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
8,04 მლრდ.
9,42 მლრდ.
10,03 მლრდ.
10,63 მლრდ.
Cost of goods sold
-
-
778,00 მლნ.
-
Cost of revenue
-
-
778,00 მლნ.
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,16 მლრდ.
5,68 მლრდ.
6,39 მლრდ.
6,59 მლრდ.
Operating expense
6,87 მლრდ.
8,22 მლრდ.
7,99 მლრდ.
9,33 მლრდ.
Total operating expenses
6,87 მლრდ.
8,22 მლრდ.
8,77 მლრდ.
9,33 მლრდ.
Operating income
1,17 მლრდ.
1,20 მლრდ.
1,26 მლრდ.
1,30 მლრდ.
Other non operating income
197,00 მლნ.
194,00 მლნ.
-620,00 მლნ.
290,00 მლნ.
EBT including unusual items
1,33 მლრდ.
1,35 მლრდ.
1,05 მლრდ.
1,53 მლრდ.
EBT excluding unusual items
1,33 მლრდ.
1,35 მლრდ.
944,00 მლნ.
1,53 მლრდ.
Income tax expense
310,00 მლნ.
318,00 მლნ.
254,00 მლნ.
365,00 მლნ.
Effective tax rate
23,29%
23,61%
24,17%
23,90%
Other operating expenses
1,48 მლრდ.
2,15 მლრდ.
1,18 მლრდ.
2,30 მლრდ.
Net income
1,02 მლრდ.
1,03 მლრდ.
797,00 მლნ.
1,16 მლრდ.
Net profit margin
12,70%
10,92%
7,94%
10,93%
Earnings per share
4,23
4,26
3,94
4,81
Interest and investment income
-
-
363,00 მლნ.
-
Interest expense
-38,00 მლნ.
-46,00 მლნ.
-39,00 მლნ.
-64,00 მლნ.
Net interest expenses
-38,00 მლნ.
-46,00 მლნ.
324,00 მლნ.
-64,00 მლნ.
Depreciation and amortization charges
234,00 მლნ.
396,00 მლნ.
418,00 მლნ.
441,00 მლნ.
EBITDA
1,40 მლრდ.
1,33 მლრდ.
1,49 მლრდ.
1,53 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები